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Background
Hematopoietic progenitors are generated in the yolk sac and aorta-gonad-mesonephros
region during early mouse development. At embryonic day 10.5 the first hematopoietic
stem cells emerge in the aorta-gonad-mesonephros. Subsequently, hematopoietic stem
cells and progenitors are found in the fetal liver. The fetal liver is a potent hematopoietic
site, playing an important role in the expansion and differentiation of hematopoietic pro-
genitors and hematopoietic stem cells. However, little is known concerning the regulation
of fetal liver hematopoietic stem cells. In particular, the role of cytokines such as inter-
leukin-1 in the regulation of hematopoietic stem cells in the embryo has been largely unex-
plored. Recently, we observed that the adult pro-inflammatory cytokine interleukin-1 is
involved in regulating aorta-gonad-mesonephros hematopoietic progenitor and
hematopoietic stem cell activity. Therefore, we set out to investigate whether interleukin-
1 also plays a role in regulating fetal liver progenitor cells and hematopoietic stem cells.
Design and Methods
We examined the interleukin-1 ligand and receptor expression pattern in the fetal liver.
The effects of interleukin-1 on hematopoietic progenitor cells and hematopoietic stem
cells were studied by FACS and transplantation analyses of fetal liver explants, and in vivo
effects on hematopoietic stem cell and progenitors were studied in Il1r1–/– embryos.
Results
We show that fetal liver hematopoietic progenitor cells express the IL-1RI and that inter-
leukin-1 increases fetal liver hematopoiesis, progenitor cell activity and promotes
hematopoietic cell survival. Moreover, we show that in Il1r1–/– embryos, hematopoietic
stem cell activity is impaired and myeloid progenitor activity is increased. 
Conclusions
The IL-1 ligand and receptor are expressed in the midgestation liver and act in the physi-
ological regulation of fetal liver hematopoietic progenitor cells and hematopoietic stem
cells. 
Key words: Interleukin-1, hematopoiesis, hematopoietic stem cell, fetal liver, aorta-gonad-
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ABSTRACT
Interleukin-1 regulates hematopoietic progenitor and stem cells 
in the midgestation mouse fetal liver 
Claudia Orelio, Marian Peeters, Esther Haak, Karin van der Horn, and Elaine Dzierzak
Erasmus University Medical Center, Department of Cell Biology and Genetics, Rotterdam, The Netherlands
Introduction
The adult hematopoietic system consists of at least
ten distinct blood cell lineages that are produced
through the differentiation of hematopoietic stem cells
(HSCs) and many intermediate progenitor cells. In the
developing mouse, the first long-term adult repopulat-
ing HSCs are found at embryonic day 10.5 (E10.5) in the
intra-embryonic aorta-gonad-mesonephros (AGM)
region.1,2 Slightly later, from E11 onwards these HSCs
are detected in other hematopoietic tissues, including
the fetal liver (FL).3,4 The FL commences its role as an
important embryonic hematopoietic organ at late E9.5,6
Between E11 and E16 HSC numbers are increased dra-
matically in the FL and subsequently remain constant
until birth,3,4,7 when the bone marrow takes over as the
HSC niche through the adult stages of life. The FL also
plays a crucial role in erythropoiesis and hematopoietic
progenitor cell expansion.8-10
In contrast to the AGM region, which harbors a
microenvironment suitable for the generation of HSCs,
the FL does not generate HSCs de novo, but is thought to
be seeded with HSCs from other embryonic sites (i.e.
the AGM and/or the yolk sac). 3,5,6,11,12 Subsequent to col-
onization by hematopoietic cells, the FL provides an
excellent in vivo environment for HSCs, as demonstrat-
ed by the dramatic increase in HSC activity during
midgestation.4,7 Also, several FL stromal cell lines have
been shown to maintain and/or expand HSCs in vitro,
further indicating that the FL contains an HSC support-
ive microenvironment.13-15
Despite the fact that the FL is a pivotal territory for
HSCs during development, little is known about the
cytokines and growth factors that affect
hematopoiesis, and more specifically hematopoietic
progenitors and HSCs, within this tissue. Previously,
we have shown that the interleukin-1 (IL-1) signaling
component TAB2 is expressed in the AGM region at
the time of HSC appearance.16 Additionally, we
observed that several IL-1 receptor/signaling compo-
nents are expressed in the midgestation AGM and that
IL-1 increased AGM HSC activity and hematopoiesis.17
This was a very interesting observation since Il1r–/–
adult mice are viable and show no obvious defects in
HSC activity or steady-state hematopoiesis.18,19 Since
TAB2, the signaling IL-1 receptor type I and its co-
receptor IL-1R associating protein (IL-1RAcP), the
decoy IL01R type II and IL-1R signaling components
were expressed in the FL, we set out to investigate
whether IL-1 may also regulate FL hematopoiesis. It is
well-documented that the pro-inflammatory cytokine
IL-1 regulates adult hematopoiesis and plays a role in a
number of diseases, including autoimmune diseases
and leukemia.20 Besides regulating mature, differentiat-
ed hematopoietic cells, functional studies show that IL-
1 regulates adult BM HSCs by providing these cells
with differentiation and/or proliferation and radio-pro-
tective signals.21-25 Since IL-1 and the IL-1 receptor type
I and the co-receptor IL-1RAcP are expressed by BM
hematopoietic stem/progenitor cells, it has been sug-
gested that IL-1 acts directly on these immature cells at
the base of the hematopoietic hierarchy.26-28 In this
study we examine whether IL-1 plays a role in FL
hematopoiesis. We show that the IL-1 receptor type 1
(IL-1RI) is expressed on FL hematopoietic (progenitor)
cells and that its ligand IL-1 is also expressed in this tis-
sue. The addition of exogenous IL-1 to FL explants
increases hematopoietic progenitor activity and the
overall number of hematopoietic cells but does not
alter HSC activity. However, when analyzing Il1r1–/–
mice, we observed that FL HSC activity was severely
impaired, while myeloid progenitor activity was
increased. Hence, IL-1 appears to be a complex regula-
tor of hematopoiesis in the FL.
Design and Methods
Embryo generation and cell culture and progenitor
assay
Animals were housed according to institutional
guidelines, with free access to water and food. Animal
procedures were carried out in compliance with the
Standards for Humane Care and Use of Laboratory
Animals. Matings for embryo generation were between
(CBAxC57BL/10) F1 females and Ln72 human β-globin29
males, C57BL/6 females and Act-GFP males,30 C57BL/6
males and females, and Il1r1–/– (Il1rtm1Imx/ tm1Imx)18 males and
females. The day of the vaginal plug was counted as day
0. Pregnant mice were sacrificed, embryos isolated, and
livers were dissected31 and resuspended in PBS/10%
FCS/1% Pen/Strep as single cells. 
Cells from 3-4 pooled fetal livers were seeded at
0.5×104 to 7.5×104 cells per plate in methylcellulose
medium (Methocult GF M3434; Stem Cell
Technologies Inc.) containing SCF, IL-3, IL-6 and Epo
and incubated at 37°C, 5% CO2. Colony-forming unit-
granulocyte, macrophage, granulocyte macrophage and
granulocyte erythroid megakaryocyte macrophage
(CFU-G, -M, -GM and –GEMM respectively) and burst-
forming unit-erythroid (BFU-E) were scored with an
inverted microscope at day 7 of culture.
RNA isolation, cDNA synthesis and RT-PCR analysis
Total RNA was isolated with TRIZOL, cDNA gener-
ated with Superscript II reverse transcriptase
(Invitrogen/ Life Technologies), and PCR reactions per-
formed with Amplitaq (PerkinElmer) as previously
described.17 PCR primer sequences are listed in the
Online Supplementary Table S1. 
Immunohistochemistry
Embryos were snap-frozen in TissueTek (Sakura). 7-
10 µM cryosections were fixed in 2% paraformalde-
hyde/PBS and stained with IL-1α antibody (clone 12A6;
BD Biosciences) as previously described.17 Pictures were
taken with an Olympus BX40 microscope (Olympus
Nederland B.V., Zoetewoude, NL) using an Olympus
lens at 20x/0.40 PH and 40x. Images were acquired and
processed with Adobe Photoshop version 7.0 (Adobe
Systems, San Jose, CA, USA). 
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Organ cultures and in vivo transplantation assays 
for hematopoietic stem cell activity 
E11 liver tissues (marked with GFP, human β-globin)
were dissected and 2-3 day organ cultures were per-
formed in the presence of 0, 1 or 10 ng/mL IL-1β
(TebuBio). To inhibit IL-1 signaling, 50 ng/mL IL-1Ra
(R&D systems) or 100 ng/mL IL-1a blocking antibody
(R&D systems) was added to the cultures. After culture,
single cell suspensions were obtained and different cell
dilutions (measured as embryo equivalents) were inject-
ed intravenously together with non-marked 2x105 spleen
cells into 9.5 Gray irradiated (CBAxC57BL/10)F1 or
(129SvxC57BL/6)F1 recipient mice. E11 liver tissues
were isolated from Il1r1+/+ and Il1r1–/– E11 male embryos
and injected intravenously together with 2x105 normal
female spleen cells into 9.5 Gray irradiated C57BL/6
female recipient mice. Repopulation was assayed at one
and four months post-transplantation by donor specific
PCR (human β-globin, GFP, Y chromosome gene) on
peripheral blood DNA as previously described.31,32 Only
mice with >10% engraftment were considered repopu-
lated. For multi-lineage repopulation analysis, DNA was
isolated from spleen, thymus, bone marrow and periph-
eral blood or from FACS-sorted cells from these tissues
and assayed for donor contribution by PCR. 
FACS analysis
Single cell suspensions were stained with IL-1RI-PE
antibody (clone 35F5, Becton Dickinson) on ice for 30
minutes. Cells were co-stained with FITC labeled anti-
bodies for c-kit (CD117), Mac-1 (CD11b), CD45 or
CD31 (Pharmingen). Dead cells were excluded by 7AAD
(Molecular Probes) and FACS analysis was performed on
FACScan (Becton Dickinson). Other FACS analyses were
performed with FITC-anti-Mac1 (CD11b), PE-anti-
CD34 (RAM34), APC-anti-c-kit (CD117) (clone 2B8) or
PerCPCy5.5-anti-CD45 (BD) antibodies. Dead cells
were excluded by Hoechst 33258 (1 mg/mL, Molecular
Probes). Analysis was performed on FACS Aria (Becton
Dickinson) and with Cell Quest software.
Statistical analysis
Data are expressed as mean ± SEM. Differences were
considered to be significant at p<0.05 as analyzed with
the Student’s t test. 
Results
Fetal liver hematopoietic cells express IL-1RI 
Previously we observed IL-1 ligand and receptor RNA
expression in E11-E12 FL tissues.17 Moreover, IL-1-
induced gene expression and signaling in E11-E12 FL
cells indicated that the IL-1 pathway was functional. To
examine which cell types could be affected by IL-1, flow
cytometric analysis for IL-1RI expression was per-
formed. On average, 5.1% of E11.5 and 3.5% of E12.5
FL cells (Table 1) express the IL-1RI. As the total number
of FL cells increases 7.6 fold between E11.5 and E12.5
(4.9×105±1.0x105 and 37×105±11x105 respectively), there
is a 5.2 fold increase in the absolute number of FL IL-1R+
cells, from 0.24×105 to 1.26×105. Multi-parameter flow
cytometric analysis with the pan-hematopoietic marker
CD45 revealed that E11.5 and E12.5 FL contain on aver-
age 1.1% and 0.3% IL-1RI+CD45+ cells respectively
(Figure 1A and Table 1), indicating that 22% and 9% of
the IL-1RI+ population is hematopoietic in E11.5 and
E12.5 FL cells respectively. Moreover, 1.3% and 0.7% of
E11.5 and E12.5 FL cells respectively are IL-1RI+c-kit+,
suggesting that 22% to 27% of the IL-1RI+ are
hematopoietic progenitor/stem cells. This is supported
by flow cytometric analysis demonstrating that some FL
IL-1RI+ cells express CD31 and Mac1 (data not shown),
markers of FL HSCs and myeloid cells.4,33
In addition to the expression of the IL-1RI, the ligand
IL-1β is expressed in discrete small patches of cells as
shown by immunostaining of E12.5 FL (Figure 1B). Flow
cytometric analysis revealed that 0.04-0.12% of FL cells
express the IL-1α ligand (data not shown). Thus, both IL-
1 expressing cells and putative IL-1 responsive cells are
present in the fetal liver. 
Interleukin-1 increases the number of fetal liver
hematopoietic cells
To determine whether IL-1 affects hematopoietic cells,
FL explants cultured in the presence or absence of IL-1
were examined by flow cytometric analysis. As shown
in Figure 2A, IL-1 increases the percentage of FL CD45+,
c-kit+ and Mac1+ cells in a dose-dependent manner.
Addition of 1 ng/mL IL-1 increased percentages 1.4 to
1.6 fold, and 10 ng/mL IL-1 significantly increased these
populations 1.7 to 2.3 fold as compared to control cul-
tures. Since IL-1 did not affect total cell numbers in cul-
tured liver explants (Online Supplementary Figure S1), the
absolute numbers of CD45+, c-kit+ and Mac-1+ cells were
similarly increased.
Blocking experiments with a natural IL-1 receptor
antagonist IL-1Ra (which binds to the IL-1RI but does
not evoke receptor signaling) or an IL-1α specific block-
ing antibody were performed to test whether
hematopoietic cell increases were specific to IL-1 signal-
ing. IL-1Ra significantly decreased the percentage of
CD45+ and c-kit+ cells in the cultures by an average of 0.8
and 0.7 fold respectively (Figure 2B), as did the IL-1α
blocking antibody (data not shown). Thus, endogeneous
IL-1 allows specific expansion of FL hematopoietic cells
in ex vivo tissue cultures.
Table 1. Percentages of IL-1RI+ hematopoietic cells in E11 and E12
fetal liver. 
E11-11.5 FL E12-12.5 FL
Mean % (range) Mean % (range)
IL-1RI+CD45– 4.0 3.5-4.5 3.2 1.8-4.2
IL-1RI+CD45+ 1.1 0.7-1.5 0.3 0.1-0.6
IL-1RI–CD45+ 11.6 10.1-15.3 6.6 5.6-7.0
IL-1RI+c-kit– 3.5 3.0-4.3 2.5 1.7-2.8
IL-1RI+c-kit+ 1.3 1.1-1.7 0.7 0.2-1.1
IL-1RI–c-kit+ 22.9 15.3-39.4 12.5 9.9-14.4
Combined IL-1RI flow cytometric data from several independent experiments in
which E11-E11.5 FL (n=5) and E12-E12.5 FL (n=4) from age-matched littermates
were pooled for analysis.
Interleukin-1 affects on fetal liver gene expression
and apoptosis 
The consequences of IL-1 mediated signaling in the FL
(gene expression changes) were monitored by RT-PCR
for components of the IL-1 signaling pathway, other
cytokine genes and cell survival-related genes. The gene
expression levels of IL-1 signaling components and
cytokine genes, Csf1 (M-CSF), Csf3 (G-CSF) and Kitl
(SCF) did not change in the FL explants cultured in the
presence of IL-1 (Online Supplementary Figure S2).
However, as shown in Figure 3A, while the expression
of anti-apoptotic genes, Bcl2 and Slugh in the FL were
unaffected by addition of 1 and 10 ng/mL of IL-1 as
compared to uncultured FL or FL explants cultured with-
out IL-1, Bcl2l1 (Bcl-x) gene expression was up-regulated
in an IL-1 dose dependent manner. The pro-apoptotic
Bax and Bim genes were unaffected by IL-1 addition.
Thus, IL-1 could be influencing the viability of FL
hematopoietic cells through the modulation of apoptot-
ic pathways.
To test this, flow cytometric analysis for the pre-
apoptotic marker, AnnexinV, in combination with
CD45 and c-kit was performed on FL explants. After 2
days of culture, the percentage of AnnexinV+ cells in the
CD45+ FL cell population was significantly decreased in
the presence of IL-1 (Figure 3B). The percentage of
apoptotic cells in the c-kit+ FL cell population was simi-
larly decreased in the presence of IL-1 (data not shown).
Thus, IL-1 affects FL hematopoietic cells by promoting
cell survival.
Interleukin-1 increases fetal liver hematopoietic 
progenitor activity
The effects of exogenously added IL-1 on FL HSCs
was tested by in vivo transplantation experiments. Cells
from E11.5 liver explants cultured in the absence or
presence of 1 or 10 ng/mL IL-1β were injected into irra-
diated adult mice and examined one and four months
post-transplantation. As shown in Figure 4A, the low
dose of IL-1β (1 ng/mL) but not the high dose (10
ng/mL) increased the percentage of repopulated mice at
one month post-transplantation, indicating that IL-1β
increases short-term repopulating hematopoietic pro-
Effect of interleukin-1 on fetal liver HSCs
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Figure 1. IL-1 Receptor and IL-1 are expressed in the FL. (A)
Multiparameter flow cytrometric plots of E11 and E12 fetal liver
cells showing IL-1RI, CD45 (hematopoietic cell marker) and c-kit
(hematopoietic stem/progenitor marker) expression. Percentages
of single positive and double positive cells are indicated in the
quadrants. Approximately 80,000 events are shown. (B)
Immunohistochemistry for IL-1β protein expression on transversal
E12 embryo trunk sections. IL-1β expression can be detected in
discrete cell clusters indicated by the arrowheads. Cells indicated
by the arrowheads in the right panel appear to be stained in the
cytoplasm of large flattened cells. Final magnification, 200x (left)
and 400x (right). 
Figure 2. IL-1β increases hematopoiesis in the E11 FL explants.
E11 FL tissues were cultured for three days as explants in the
absence or presence (1 or 10 ng/mL) of IL-1β or IL-1R antagonist
(IL-1Ra). After this culture period, single cell suspensions were
generated, cell counts were performed (Online Supplementary
Figure S1) and the percentage of hematopoietic (CD45+), or
hematopoietic progenitor/stem cells (c-kit+ or Mac1+) was deter-
mined by flow cytometric analysis. (A) Percentages of CD45+, c-kit+
and Mac1+ cells after FL explant culture in increasing doses of IL-
1β. The bars indicate the average percentage of marker positive
cells from 5 independent experiments and the error bar indicates
the SEM. Asterisks (*) indicate statistical significance. (B) IL-1R
antagonist (IL-1Ra) addition decreases the percentage of CD45+
and c-kit+ cells in FL explant cultures. The bars indicate the aver-
age percentage of marker positive cells from 3 independent
experiments and the error bars indicate the 2xSEM. Asterisks (*)
indicate statistical significance. 
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genitor activity in the FL. In contrast, at four months
post-transplantation, neither dose of IL-1 affected long-
term repopulating HSC activity in the FL. The same per-
centages of engrafted recipients were found as with con-
trol FL cultured in the absence of IL-1. Chimerism levels
were high and engraftment was multilineage (Figure 4B).
Thus, exogenously added IL-1 increases short-term FL
hematopoietic progenitor activity in FL explants, and
does not affect long-term FL HSC activity. 
Interleukin-1 receptor deficiency affects fetal liver
hematopoietic progenitors and stem cells 
To determine if IL-1 plays a role in FL hematopoiesis
in a more physiological setting, we analyzed FLs from
E11 Il1r1–/– embryos for hematopoietic progenitor and
HSC activity. The absolute number of Il1r1–/– FL cells
(6.14×105±7.0×104 cells) is significantly increased (1.3
fold) as compared to wild type FL cells (3.7×105±2.5×104
cells; n=6-9). Flow cytometric analyses showed that
although the percentage of FL CD45+ cells in Il1r1–/–
embryos (8.3%) was slightly lower as compared to wild
type embryos (11.4%), the absolute number of CD45+ FL
cells was similar (4.0-4.2×104). Also, no differences were
found in the absolute number of cells expressing Mac1
(1.8×104±9.2×103 in Il1r1+/+ FL; 1.8×104±2.0×103 in Il1r1–/–
FL) or c-kit (2.5×105±2.1×104 in Il1r1+/+ FL;
2.8×104±1.7×104 in Il1r1–/– FL). Interestingly, the absolute
number of CD34+Mac1+c-kit+ cells (phenotypic HSCs)
was 1.3-fold decreased and the absolute number of Gr1+
myeloid (progenitor) cells was 2.1-fold increased in the
Il1r1–/– FL as compared to wild type FL (Figure 5A). 
In clonogenic progenitor assays (Figure 5B), BFU-E
numbers were decreased by 1.9-fold in the Il1r1–/– FL.
CFU-M and CFU-G were 1.9-fold and 1.3-fold increased
in Il1r1–/– FL. CFU-GM, the common progenitor for CFU-
M and CFU-G, showed no significant (1.2-fold) increase
in the Il1r1–/– FL, but a striking 2.5-fold decrease was
found for the CFU-GEMM, the most immature multi-
potent progenitor. Together with the phenotypical
analyses, these progenitor activity data suggest that IL-1
signalling in vivo differentially affects mature myeloid
progenitors and immature multi-potent hematopoietic
progenitors.
The effect of in vivo FL IL-1 signaling on HSC activity
was examined by long-term transplantation studies with
Figure 3. IL-1 affects apoptosis-related gene expression levels and
hematopoietic apoptosis in FL explants. E11.5 FL tissues were
directly analyzed or analyzed after culture for three days in the
presence or absence of 1 or 10 ng/mL IL-1β. (A) RT-PCR gene
expression analysis for the anti-apoptotic genes Bcl-2 (Bcl2), Slugh
and Bcl-x (Bcl2l1) and the pro-apoptotic Bax and Bim genes.
Expression was normalized against the housekeeping gene actin.
(B) FACS analysis of E11.5 FL explants for apoptotic marker
AnnexinV. Bar graph indicates the fold induction of the average
percentage of AnnexinV+ (apoptotic) cells within the hematopoiet-
ic (CD45+) FL cell population after two days of explant culture in
the presence or absence of IL-1. Error bars indicate the SEM (n=3)
and asterisks (*) indicate statistical significance. RT=reverse tran-
scriptase.
Figure 4. IL-1β increases short-term, but not long-term HSC activ-
ity in FL tissues. E11.5 FL explants were cultured in the absence
or presence of 1 or 10 ng/mL IL-1β. Single cell suspensions were
obtained and injected into lethally irradiated recipients. At one
and four months post-transplantation the peripheral blood was
tested for donor contribution to the hematopoietic system by
semi-quantitative PCR. (A) Combined results from 7 independent
experiments in which one embryo equivalent (ee) of cultured FL
cells were injected per recipient. Bars indicate the percentage of
repopulated mice per condition after one and four months post-
transplantation. The numbers above the bars indicate the number
of repopulated recipients out of the total number of injected recip-
ients. SE ranged from 10-13% and the one month result with 1 ng
IL-1 shows a statistically significant difference from the other
repopulation results. Only mice with >10% donor chimerism were
considered repopulated and multi-lineage repopulation was con-
firmed in several recipients. (B) Representative multi-lineage
analysis for 2 recipients that were injected with FL cells cultured
in the presence of 1 or 10 ng/mL of IL-1. All hematopoietic tis-
sues analyzed by semi-quantitative PCR show high levels of donor
contribution, confirming that IL-1 does not compromise the ability
of the FL HSCs to allow multi-lineage reconstitution of the recipi-
ent. 
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freshly isolated and three day cultured Il1r1–/– and Il1r1+/+
FLs. As shown in Figure 5C, direct transplantation of
Il1r1–/– FL cells resulted in fewer repopulated mice (13%)
as compared to the number repopulated with wild type
cells (71%). After three days of culture, HSC activity in
Il1r1+/+ FL explants was reduced (20%) compared to HSC
activity in directly isolated FL demonstrating the subop-
timal conditions of FL explant cultures for supporting
HSCs. 
Despite the suboptimal conditions, the Il1r1–/– FL
explants did not experience further significant losses in
HSC activity. Thus, the lack of in vivo IL-1R1 signaling in
the FL leads to decreased immature hematopoietic pro-
genitor (CFU-GEMM) and HSC numbers, and a con-
comitant increase in CFU-M.
Discussion
We have shown here that the well-known adult pro-
inflammatory cytokine IL-1 plays a role in the regulation
of FL hematopoietic cells, progenitors and HSCs during
midgestation development. Both the IL-1 ligand and the
signal transducing IL-1R type I and IL-1RAcP, as well as
the IL-1R type II decoy receptor are expressed by E11-
E12 FL hematopoietic cells and progenitors. In ex vivo FL
explant cultures exogenously added IL-1 induces an
increase in hematopoietic cell numbers and these
increases are IL-1 dose dependent. Thus, FL hematopoi-
etic cells are sensitive to IL-1. IL-1 also increases short-
term repopulating hematopoietic progenitor numbers in
ex vivo FL explant cultures. However, increases were
found at 1 ng/mL and not 10 ng/mL of IL-1, indicating
that subsets of hematopoietic cells are differentially sen-
sitive to IL-1 dose. 
To examine more carefully the affects of IL-1 signaling
on hematopoietic cells, we analyzed IL-1RI deficient
embryos for FL hematopoietic defects. Directly analyzed
E11 Il1r1–/– FL revealed decreases in the absolute number
of c-kit+Mac1+CD34+ phenotypic HSCs (1.3-fold) and
CFU-GEMM immature hematopoietic progenitors (2.5-
fold). We found that HSC activity is severely (3.3-fold)
decreased. Taken together, IL-1 signaling in vivo appears
to contribute to the expansion and/or maintenance of
most FL HSCs. As expected, based on the absence of a
steady state hematopoietic phenotype in Il1r1–/– adult
mice,18 the Il1r1–/– FL was not completely deficient in
HSC activity, suggesting that IL-1 is not absolutely
required. Further studies should provide insight into the
IL-1 independent HSC subset that apparently provides
for the relatively normal hematopoiesis found in adult
Il1r1–/– mice. A more careful analysis of HSC activity,
number and self-renewal capacity of Il1r1–/– adult mice
could in future studies provide a better insight into HSC
regulation by inflammatory cytokines. 
In contrast to the HSCs and immature progenitors
(CFU-GEMM), the number of CFU-M and Gr-1+ cells
was increased in the Il1r1–/– FL. These data suggest an
additional role for IL-1 signaling in vivo, perhaps acting to
limit myeloid cell expansion. FACS analysis of Il1r1–/– FL
cells for CMP, GMP, MEP and CLP should provide
insight into which specific cell in the lineage hierarchy is
affected. Our data do not allow discrimination as to
whether IL-1 would act directly on IL-1RI expressing
hematopoietic progenitors or indirectly on the cells of
the FL microenvironment (4.4% of FL cells are CD45-IL-
1RI+; Figure 1A) that in turn affect hematopoietic progen-
itors. Alternatively, IL-1 signaling may limit the differen-
tiation of HSC to myeloid progenitors in vivo. Initially we
used the ex vivo explant culture system to examine these
possibilities. 
However, neither FL explants cultured with exoge-
nously added IL-1 nor IL-1R deficient FL explants were
changed in HSC activity. In fact, HSC activity in wild
type FL explants is vastly decreased as compared to
freshly isolated FL tissue,3,5,6,11,12 indicating that FL
explants (in contrast to AGM explants) do not have the
appropriate microenvironment for autonomous ex vivo
HSC maintenance or expansion. Hence, on its own, IL-1
cannot mediate FL HSC expansion ex vivo. 
Developmental similarities in IL-1 mediated
hematopoietic cell regulation
Recently, we showed that IL-1 plays a role in limiting
the progenitor differentiation in the midgestation AGM
and that IL-1R deficiency results in decreased AGM
HSC activity.17 Compared to the AGM region, the levels
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Figure 5. IL-1R deficiency affects FL hematopoietic progenitors
and HSCs in vivo. E11 FLs were dissected from wild type (Il1r1+/+;
white bars) or Il1r1–/– (gray bars) embryos and assayed. (A) The
absolute number of c-kit+Mac1+CD34+ cells and Gr-1+ cells in
Il1r1+/+ and Il1r1–/– FL as determined by flow cytometric analysis.
Percentage marker positive cells and total viable FL cells were
used to calculate absolute cell numbers per FL. Asterisk (*) indi-
cates statistical significance. Results represent the average ± SEM
of at least 5 experiments. (B) Progenitor numbers per Il1r1+/+ and
Il1r1–/– FL as determined by methylcellulose clonogenic assay.
Total numbers of BFU-E, CFU-M, CFU-G, CFU-GM and CFU-GEMM
per FL are shown. Colony numbers are derived from triplicate cul-
tures scored after seven days of culture (n=3, cells from 14 Il1r1+/+
and 15 Il1r1–/– FLs). Asterisks (*) indicate statistical significance.
(C) Percentage of adult recipient mice repopulated with HSCs
from Il1r1+/+ and Il1r1–/– FLs either directly transplanted (direct) or
transplanted after three days of explant culture (explant).
Numbers of mice repopulated/number of mice transplanted are
indicated. Only mice with more than 10% donor chimerism were
considered repopulated. Statistically significant differences are
found in the repopulation results between Il1r1+/+ direct and
Il1r1+/+ explant, and between Il1r1+/+ direct and Il1r1–/– explants. 
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of IL-1RI expression, as well as the percentages of IL-
1RI+ cells are higher in the E11-E12 FL. Despite the fact
that the AGM and the FL are rather different tissues,
both in tissue architecture and cellular composition,
there are striking similarities between IL-1 mediated
hematopoietic (stem and progenitor) cell regulation.
Most interestingly, both HSC and progenitor activity are
decreased in Il1r1–/– AGM and FL, while the myeloid pro-
genitors are increased, suggesting a similar role for IL-1
signaling in these two embryonic hematopoietic
microenvironments. 
Also like in the AGM region, IL-1RI is not exclusively
expressed on CD45+ FL hematopoietic cells. In the adult
BM, we found that more than 99% of the IL-RI+ cells are
CD45+ (Orelio et al., unpublished data, 2008).
Approximately 60-90% of FL IL-1RI+ cells do not express
the CD45 or c-kit hematopoietic markers. Interestingly,
we observed IL-1RI and IL-1RAcP expression (by RT-
PCR and FACS) in several AGM and FL derived stromal
cells.17 Immunostainings of AGM tissues localize IL-1RI
expression to both hematopoietic and mesenchymal cell
regions. Despite the almost exclusive expression of IL-
1RI on adult BM hematopoietic cells, the adult BM stro-
mal cell line FBMD-1 also expresses IL-1RI and IL-
1RacP.17 Thus, the expression of IL-1RI on both
hematopoietic and non-hematopoietic cells suggests
that IL-1 plays a role in regulating hematopoiesis in both
a direct and an indirect manner in both AGM and FL.
While IL-1 may act, in a limited manner, on the adult BM
microenvironment (less than 1% of the IL-R1+ cells are
CD45–), the high percentages of IL-1RI+ non-hematopoi-
etic cells in FL and AGM strongly suggest that these
embryonic microenvironments are responsive to IL-1
and consequently affect hematopoiesis.  
A role for IL-1 in regulating apoptosis of fetal liver
hematopoietic cells
The IL-1 mediated increase in hematopoietic (progen-
itor) cells in FL explant cultures suggests that IL-1 may
influence cell survival. Previously we and others have
shown that apoptosis plays a role in regulating HSCs in
the AGM, FL and BM.34-36 RT-PCR analysis revealed that
the anti-apoptotic genes Bcl2 and Bcl2l1 (Bcl-x) were
down-regulated in AGM tissues cultured in the presence
of IL-1, but flow cytometric studies with Annexin V
staining showed no consistent effect of IL-1 on the via-
bility of c-kit+ cells (Orelio et al., unpublished data, 2008).
In contrast, IL-1 did increase the expression level of the
anti-apoptotic Bcl2l1 gene in FL explants and decreased
apoptosis in the FL hematopoietic (progenitor) popula-
tion. Other studies have shown that mice deficient in IL-
1R signaling components, such as TAB2 and NFκB path-
way components (i.e. p65 NFκB and IKK) are embryon-
ic lethal, due to severe FL degeneration caused by apop-
tosis.37-40 Also, the IL-1R signaling component TAK1 is
required for BM hematopoietic cell survival.41 Taken
together, these results suggest that IL-1 receptor signal-
ing contributes to maintaining the balance between the
life and death of FL and BM hematopoietic cells. This is
further supported by many previous studies of in vivo IL-
1 administration in which IL-1 has been shown to pro-
vide radioprotection to BM hematopoietic progenitors
and stem cells.24,25,42
In conclusion, we have shown here that the pro-
inflammatory cytokine IL-1 and its receptor are
expressed in the midgestation FL and that IL-1 can act as
a regulator of HSCs and of myeloid differentiation in
this tissue. One of the possible mechanisms by which
IL-1 may regulate these hematopoietic cells is via cell
survival. Also, enhanced differentiation of HSCs and
progenitors (resulting in decreased HSC and progenitor
numbers), could contribute to increased myeloid pro-
genitor numbers. Thus, this study reveals an exciting
role for an adult cytokine in regulating the immature
hematopoietic cells during FL development. 
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